We Are One Seven LLC Takes Position in Genpact Limited (G)

We Are One Seven LLC acquired a new position in Genpact Limited (NYSE:G) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,055 shares of the business services provider’s stock, valued at approximately $383,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. lifted its holdings in shares of Genpact by 6.6% in the 4th quarter. BlackRock Inc. now owns 12,772,040 shares of the business services provider’s stock worth $405,384,000 after acquiring an additional 785,600 shares during the last quarter. Brown Advisory Inc. lifted its holdings in shares of Genpact by 2.0% in the 3rd quarter. Brown Advisory Inc. now owns 12,598,190 shares of the business services provider’s stock worth $362,198,000 after acquiring an additional 247,088 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Genpact by 10.4% in the 4th quarter. Alliancebernstein L.P. now owns 3,158,448 shares of the business services provider’s stock worth $100,249,000 after acquiring an additional 297,894 shares during the last quarter. Pzena Investment Management LLC lifted its holdings in shares of Genpact by 7.7% in the 4th quarter. Pzena Investment Management LLC now owns 2,843,211 shares of the business services provider’s stock worth $90,243,000 after acquiring an additional 204,077 shares during the last quarter. Finally, Congress Asset Management Co. MA lifted its holdings in shares of Genpact by 1.9% in the 4th quarter. Congress Asset Management Co. MA now owns 2,665,625 shares of the business services provider’s stock worth $84,607,000 after acquiring an additional 50,390 shares during the last quarter. Hedge funds and other institutional investors own 91.01% of the company’s stock.

How to Become a New Pot Stock Millionaire

Genpact Limited (NYSE:G) opened at $31.51 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.71. Genpact Limited has a one year low of $23.34 and a one year high of $34.79. The company has a market cap of $6,235.83, a price-to-earnings ratio of 23.51, a P/E/G ratio of 2.07 and a beta of 0.63.

Genpact (NYSE:G) last issued its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.02. The business had revenue of $734.41 million for the quarter, compared to the consensus estimate of $723.55 million. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.43 EPS. analysts anticipate that Genpact Limited will post 1.55 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th were given a dividend of $0.075 per share. This is an increase from Genpact’s previous quarterly dividend of $0.06. This represents a $0.30 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date of this dividend was Thursday, March 8th. Genpact’s payout ratio is presently 22.39%.

G has been the topic of several analyst reports. Zacks Investment Research downgraded shares of Genpact from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th. Citigroup decreased their target price on shares of Genpact from $39.00 to $37.50 and set a “buy” rating on the stock in a research note on Tuesday, February 13th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $36.00 target price on shares of Genpact in a research note on Tuesday, February 13th. JPMorgan Chase & Co. decreased their target price on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 14th. Finally, BMO Capital Markets lifted their target price on shares of Genpact to $35.00 and gave the stock a “market perform” rating in a research note on Tuesday, February 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $34.65.

In other Genpact news, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total transaction of $770,325.50. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director James C. Madden sold 4,270 shares of the business’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $30.92, for a total transaction of $132,028.40. The disclosure for this sale can be found here. 1.41% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “We Are One Seven LLC Takes Position in Genpact Limited (G)” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3293787/we-are-one-seven-llc-takes-position-in-genpact-limited-g.html.

Genpact Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Comparing On Assignment  & Its Competitors
Comparing On Assignment & Its Competitors
Financial Survey: Container Store Group  versus Bed Bath & Beyond
Financial Survey: Container Store Group versus Bed Bath & Beyond
Financial Analysis: Methode Electronics  and Amphenol
Financial Analysis: Methode Electronics and Amphenol
Analysts Expect Silicon Labs  Will Post Earnings of $0.76 Per Share
Analysts Expect Silicon Labs Will Post Earnings of $0.76 Per Share
Bitair Trading Up 17.7% This Week
Bitair Trading Up 17.7% This Week
DIMCOIN  Price Down 8% This Week
DIMCOIN Price Down 8% This Week


© 2006-2018 Ticker Report. Google+.